par Zardavas, Dimitros 
;Piccart-Gebhart, Martine ;Baselga, José
Référence Nature reviews. Clinical oncology, 10, 4, page (191-210)
Publication Publié, 2013-04
;Piccart-Gebhart, Martine ;Baselga, JoséRéférence Nature reviews. Clinical oncology, 10, 4, page (191-210)
Publication Publié, 2013-04
Article révisé par les pairs
| Titre: |
|
| Auteur: | Zardavas, Dimitros; Piccart-Gebhart, Martine; Baselga, José |
| Informations sur la publication: | Nature reviews. Clinical oncology, 10, 4, page (191-210) |
| Statut de publication: | Publié, 2013-04 |
| Sujet CREF: | Cancérologie |
| MeSH keywords: | Antineoplastic Agents -- pharmacology |
| Breast Neoplasms -- drug therapy -- genetics -- secondary | |
| Female | |
| Humans | |
| Molecular Targeted Therapy | |
| Neoplasm Proteins -- genetics | |
| Neoplastic Stem Cells -- drug effects | |
| Tumor Microenvironment -- drug effects | |
| Note générale: | SCOPUS: re.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1759-4774 |
| info:doi/10.1038/nrclinonc.2013.29 | |
| info:pii/NRCLINONC201329 | |
| info:scp/84875752240 | |
| info:pmid/23459626 |
